222 related articles for article (PubMed ID: 27071765)
1. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
Meyer MR; Bergstrand MP; Helander A; Beck O
Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
[TBL] [Abstract][Full Text] [Related]
2. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M; Helander A; Hansson T; Beck O
Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
[TBL] [Abstract][Full Text] [Related]
3. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
Bäckberg M; Pettersson Bergstrand M; Beck O; Helander A
Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014
[TBL] [Abstract][Full Text] [Related]
5. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
[TBL] [Abstract][Full Text] [Related]
6. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
[TBL] [Abstract][Full Text] [Related]
7. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
9. Intoxication cases associated with the novel designer drug 3',4'-methylenedioxy-α-pyrrolidinohexanophenone and studies on its human metabolism using high-resolution mass spectrometry.
Grapp M; Kaufmann C; Schwelm HM; Neukamm MA; Blaschke S; Eidizadeh A
Drug Test Anal; 2020 Sep; 12(9):1320-1335. PubMed ID: 32476242
[TBL] [Abstract][Full Text] [Related]
10. Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.
Helander A; Bäckberg M; Signell P; Beck O
Clin Toxicol (Phila); 2017 Jul; 55(6):589-599. PubMed ID: 28349714
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
12. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
13. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
14. Identifying Metabolites of Meclonazepam by High-Resolution Mass Spectrometry Using Human Liver Microsomes, Hepatocytes, a Mouse Model, and Authentic Urine Samples.
Vikingsson S; Wohlfarth A; Andersson M; Gréen H; Roman M; Josefsson M; Kugelberg FC; Kronstrand R
AAPS J; 2017 May; 19(3):736-742. PubMed ID: 28091881
[TBL] [Abstract][Full Text] [Related]
15. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
[TBL] [Abstract][Full Text] [Related]
16. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
[TBL] [Abstract][Full Text] [Related]
17. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry.
Peters RJ; van Engelen MC; Touber ME; Georgakopoulus C; Nielen MW
Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2329-37. PubMed ID: 19575408
[TBL] [Abstract][Full Text] [Related]
18. Blood concentrations of new designer benzodiazepines in forensic cases.
Høiseth G; Tuv SS; Karinen R
Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
[TBL] [Abstract][Full Text] [Related]
19. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
[TBL] [Abstract][Full Text] [Related]
20. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Schmitt S; Maurer HH
J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]